Kreipe R E, Hicks D G, Rosier R N, Puzas J E
Department of Pediatrics, University of Rochester School of Medicine and Dentistry, New York.
J Adolesc Health. 1993 Jun;14(4):319-24. doi: 10.1016/1054-139x(93)90181-n.
We performed tetracycline double-labeled bone biopsies and serial bone densitometry on four patients with anorexia nervosa to determine the effects of various conditions of sex hormone replacement and body weight status. We found negligible bone mineral apposition rate in two patients with anorexia nervosa who were taking estrogen and progestin pills while weighing only 79% of normal. However, bone mineral apposition rate was normal in two patients with anorexia nervosa who took no sex hormones and remained amenorrheic while weighing 87% of normal. Histomorphometric analysis revealed a decrease in intracortical trabecular area by 57% and an increase in active osteoblastic surface area by 300%, comparing the subjects who were taking hormone replacement to those who were not. There was no direct evidence of increased resorption in any subject. Six months after biopsy, the two subjects taking sex hormones decreased lumbar bone mineral density by 1.9%, while the two taking no sex hormones remained amenorrheic, but increased bone mineral density by 1.3%. Therefore, we propose that sex hormone therapy in the presence of persistently low body weight might be of limited benefit for bone mineral apposition and density.
我们对4例神经性厌食症患者进行了四环素双标记骨活检和系列骨密度测量,以确定各种性激素替代状况和体重状态的影响。我们发现,两名服用雌激素和孕激素药丸且体重仅为正常体重79%的神经性厌食症患者的骨矿物质沉积率可忽略不计。然而,两名未服用性激素且体重为正常体重87%并持续闭经的神经性厌食症患者的骨矿物质沉积率正常。组织形态计量学分析显示,与未接受激素替代治疗的受试者相比,接受激素替代治疗的受试者皮质内小梁面积减少了57%,活跃成骨细胞表面积增加了300%。在任何受试者中均无吸收增加的直接证据。活检6个月后,两名服用性激素的受试者腰椎骨密度降低了1.9%,而两名未服用性激素的受试者仍持续闭经,但骨密度增加了1.3%。因此,我们认为,在体重持续偏低的情况下,性激素治疗对骨矿物质沉积和骨密度的益处可能有限。